Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2021
SOHO State of the Art Updates and Next Questions: BTK inhibitors combined with chemoimmunotherapy in CLL, the best of both worlds?Philip A ThompsonBritish Journal of Haematology|February 2, 2017
How I manage patients with hairy cell leukaemiaPhilip A Thompson, Farhad RavandiHematology. American Society of Hematology. Education Program|December 9, 2022
Treatment of Richter's syndromePhilip A Thompson, Tanya SiddiqiBlood Advances|March 13, 2024
BTK inhibitors in CLL: second-generation drugs and beyondConstantine Tam, Philip A ThompsonHematology/Oncology Clinics of North America|July 8, 2025
Advances in the Understanding of Richter TransformationPhilip A Thompson, Erin M ParryExpert Opinion on Investigational Drugs|November 11, 2017
Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL)Philip A Thompson, Jan A BurgerBlood|May 8, 2023
Pirtobrutinib: a new hope for patients with BTK inhibitor-refractory lymphoproliferative disordersPhilip A Thompson, Constantine S TamCurrent Hematologic Malignancy Reports|June 15, 2013
Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysisPhilip A Thompson, H Miles PrinceBlood|November 19, 2015
Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLLPhilip A Thompson, William G WierdaAnnals of Hematology|October 25, 2017
Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapiesMaliha Khan, Rabbia Siddiqi, Philip A ThompsonPageof 7